International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC)

MIMS Doctor spoke to Dr Kho Sze Shyang, of Sarawak General Hospital, who won not one, but two awards at the recent International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC), held in Yokohama, Japan. The two papers that Kho submitted won him the IASLC International Mentorship Program and the WCLC 2017 Developing Nation Travel Awards.

Integrating robust smoking cessation programs with organized low-dose CT (LDCT) lung cancer screening may decrease mortality rates while being relatively cost-effective, according to a modelling study.

Customizing chemotherapy (CT) treatment based on BRCA1 expression levels of post-operative patients with stage II/III non-small-cell lung cancer (NSCLC) does not affect overall survival (OS) versus standard treatment, say researchers.

On-the-ground education focused on changing knowledge, beliefs and attitudes towards cancer may be key to reducing disproportionately high mortality rates among underserved minority communities, say researchers.

UK researchers confirm the International Association for the Study of Lung Cancer (IASLC)’s proposed criteria for uncertain resection margin status, R(un), in residual tumour classification.

The introduction of heat-not-burn cigarettes may lead to dramatic changes in lung cancer incidences and types of lung cancers, says an expert.

According to an expert, race and specific socioeconomic factors such as insurance, income, education and location influence the outcome of patients with non-small cell lung cancer (NSCLC).